Skip to content

Jason P Rhodes, Director at Dyne Therapeutics, sold DYN on Jun 25, 2026

Data as of Oct 16

▼ SELL$268K12,699 shares at $21.10Jason P Rhodes DirectorDYN Dyne Therapeutics, Inc.
Watch DYN
Traded
Jun 25, 2026
Disclosed
Jun 26, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jason P Rhodes, Director at Dyne Therapeutics, sold DYN on Jun 25, 2026TRADEDDISCLOSED
DYNSimilar stocks (XLV — its sector index fund), rebased to DYN's price on the disclosure day
DYN since disclosure
−31.9%
after the sale
Similar stocks (XLV) since disclosure
+10.2%
XLV — its sector index fund

Change in closing price from Jun 26, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$106Kdisclosed Jun 26 · filed 1 day after the trade
  2. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$135Kdisclosed Jun 26 · filed 1 day after the trade
  3. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$534Kdisclosed Jun 26 · filed 2 days after the trade
  4. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.1Mdisclosed Jun 26 · filed 2 days after the trade
  5. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$420Kdisclosed Jun 26 · filed 2 days after the trade
  6. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$1.6Mdisclosed Jun 26 · filed 3 days after the trade
  7. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$650Kdisclosed Jun 26 · filed 3 days after the trade
  8. ▼ SELLJason P Rhodes DirectorDYN Dyne Therapeutics, Inc.$827Kdisclosed Jun 26 · filed 3 days after the trade

See every trade on DYN →